Founded in 1986, Purna Pharmaceuticals is a Belgian FDA-inspected pharmaceutical manufacturer specializing in semi-solid and liquid dosage forms.

As a trusted partner to pharmaceutical companies worldwide, we combine personalized support and flexible collaboration with the quality, compliance and reliability of an established pharmaceutical manufacturer.
From innovative start-ups to global pharmaceutical organizations, we help our customers bring products to market through tailored solutions, regulatory expertise and an uncompromising commitment to quality.

100%

GMP compliant and FDA inspected

Continuously compliant facility meeting rigorous European regulatory standards.

40+ Years

Manufacturing & development experience

Unlocking stable formulation chemistry and reliable manufacturing pipelines since 1986.

200+

Active Client Base

Trusted by small scale biotech start-ups to Fortune 500 pharmaceutical giants.

partner_team_img

Four Decades of Pharmaceutical Excellence

Explore the key milestones that shaped Purna Pharma from a regional manufacturer in 1986 to a leading international contract development and manufacturing organization (CDMO).

FOUNDATION & TRUST

1986 – 1995

Founder R. Van Gucht purchases first site (Building 1 in Puurs); production shifts from export market to essential drugs for non-government org. (NGO’s
COMMERCIAL MANUFACTURING

1996

First CMO activities begin
EVOLUTION

2015

Purna evolved from CMO to CDMO and began offering development services
R&D EXPANSION

2016 – 2017

Purna begins development of internal R&D projects with out-licensing potential
CLINICAL CAPABILITY

2019 – 2020

Finished new IMP production area (two production rooms, weighing booth, cleaning room, material and personnel lockers)
  • Expanded solid dose development capabilities (tableting machine, capsulating machine and lab equipment)
PROCESS EXCELLENCE

2021

Added new RO water installation (including 25k buffer vessel) and implemented MES Pharmasuite
REGULATORY MILESTONE

2021 – 2022

Strategic shift from high volume / low margin to low volume / high margin projects
COMPLIANCE & STRATEGY

2022

Strategic shift from high volume/low margin to low volume / high margin projects
NOW

2023

Completed first successful FDA audit (no actions indicated) and started first production for US
  • Added new Building Monitoring System (BMS) Yokogawa
NOW

2025

Started first production and supply to China
mission_icon

Our Mission

We combine the flexibility and personal commitment of a dedicated partner with the quality standards of a leading pharmaceutical manufacturer. Our mission is to support customers throughout the product lifecycle, delivering innovative liquid and semi-solid solutions that create lasting value.

Mission_img
mission_icon

Engagement

Commitment, taking responsibility, initiative and continuous improvement.

mission_icon

Reliability

We aim to be reliable partners to all our customers, suppliers, staff and shareholders.

mission_icon

Teamspirit

Strong collaboration and mutual respect are the foundation of everything.

Why partner with Purna

why_purna_img_box
The partner Voyage

Defined partner process

  • Starting a pharmaceutical development or manufacturing project is much like setting sail on a long voyage. We leave the harbour together, united by a common goal and committed to reaching our destination. Along the way, challenges may arise, priorities may evolve, and the course may need to be adjusted
  • But with the right partner and a well-aligned team, obstacles can be anticipated, managed and overcome efficiently. Together, we stay focused on the destination, ensuring a smooth and successful journey from concept to commercialization.
Partnership Philosophy

Intimacy - Long-term partnerships - Tailored solutions

  • We believe in long-term partnerships, not one-time transactions. By fostering close relationships and direct communication, we become an extension of our customers' teams.
  • Our accessible, hands-on approach ensures fast responses, flexible solutions and personal support from the people who know your project best. Combined with pharmaceutical-grade expertise and quality, this allows us to support our partners efficiently at every stage of development and manufacturing.
why_purna_img_box

Our Leadership Team

team_img

Marc Verbruggen

Managing Director

team_img

Dennis Van Cotthem

Financial Director / CFO

team_img

Wim Vanderaerden

Operational Director

team_img

Bert Van Peteghem

Quality Director

team_img

Yves Peeraer

Qualified Person

team_img

Wesley De Jaeghere, Ph.D.

BD/RD Director

team_img

Kirsten Cools

HR Director

Our Professional

team_img

Dr. Emily De Smet

Doctorate in Manufacturing Engineering.

team_img

Lucas Maes

PhD in Advanced Manufacturing Systems.

team_img

Siddharth Mehta

PhD in Manufacturing Technology.

team_img

Dr. An Miller

Doctorate in Production Engineering.

team_img

Dr. Emily De Smet

Doctorate in Manufacturing Engineering.

team_img

Lucas Maes

PhD in Advanced Manufacturing Systems.

team_img

Siddharth Mehta

PhD in Manufacturing Technology.

team_img

Dr. An Miller

Doctorate in Production Engineering.